Allspring Global Investments Holdings LLC Purchases 8,985 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Allspring Global Investments Holdings LLC boosted its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 3.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 274,585 shares of the company’s stock after buying an additional 8,985 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in BlackRock Health Sciences Term Trust were worth $4,023,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Bell Private Wealth Management LLC grew its position in shares of BlackRock Health Sciences Term Trust by 391.2% in the fourth quarter. Blue Bell Private Wealth Management LLC now owns 72,657 shares of the company’s stock valued at $1,064,000 after purchasing an additional 57,865 shares during the last quarter. Stratos Wealth Advisors LLC acquired a new stake in BlackRock Health Sciences Term Trust in the 4th quarter valued at approximately $170,000. Kingswood Wealth Advisors LLC bought a new position in BlackRock Health Sciences Term Trust in the 4th quarter worth approximately $295,000. B. Riley Wealth Advisors Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 4.8% during the third quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock worth $250,000 after buying an additional 796 shares during the last quarter. Finally, Walleye Capital LLC boosted its position in shares of BlackRock Health Sciences Term Trust by 45.5% in the third quarter. Walleye Capital LLC now owns 27,907 shares of the company’s stock valued at $402,000 after acquiring an additional 8,732 shares during the period.

Insider Activity at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. purchased 46,421 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were purchased at an average cost of 16.33 per share, for a total transaction of 758,054.93. Following the completion of the purchase, the insider now directly owns 20,538,431 shares of the company’s stock, valued at approximately 335,392,578.23. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Over the last 90 days, insiders purchased 2,110,279 shares of company stock worth $33,167,471.

BlackRock Health Sciences Term Trust Trading Down 0.5 %

NYSE:BMEZ opened at 14.44 on Friday. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.60. The company has a fifty day moving average price of 15.96 and a 200 day moving average price of 14.92.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Monday, April 15th will be given a dividend of $0.09 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 7.48%. The ex-dividend date of this dividend is Friday, April 12th.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.